Article metrics

other Versions

Download PDFPDF

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial

 

Online download statistics by month:

Online download statistics by month: March 2024 to June 2024

AbstractFullPdf
Mar 2024431442172
Apr 2024305289125
May 202415113071
Jun 2024858050
Total972941418